Back to search results

Using Personal Continuous Glucose Monitors (CGM) in the Hospital for Diabetes Control

This study is looking at whether using your personal continuous glucose monitor (CGM) while you're in the hospital can help manage your diabetes better. Researchers will monitor your CGM data in real-time and use it, along with your regular blood sugar readings, to adjust your insulin doses. The goal is to improve your blood sugar control and reduce episodes of very high or very low blood sugar. You might be able to join if you are an adult with diabetes, are already using a personal CGM, are receiving insulin, and are expected to stay in the hospital for more than 48 hours in a non-intensive care unit (non-ICU) setting or through an Advanced Care at Home Program. The study will compare blood sugar levels and the amount of time your blood sugar stays in a healthy range.

Study design
This is a single-center, randomized, unblinded, crossover study involving 150 participants. It will compare two groups: one where CGM data is continuously accessed and one where it is not.
What's involved
You will share 14 days of your outpatient CGM data and all CGM data recorded during your hospital stay. You will also continue to monitor your CGM with your personal reader/phone and inform nurses of any alarms.
Compensation
Not stated in the trial record.
Follow-up
Your glucose levels and time in range will be measured from your admission date to your discharge date, up to 8 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07006480

Inpatient Use of Personal Continuous Glucose Monitor (CGM) to Improve Diabetes Mellitus Control

Recruiting
NAAges 18+InterventionalTreatment
Mayo Clinic
~150 participants
Updated 2026-07-15 on ClinicalTrials.gov
What's tested:Real time CGM data monitoringInsulin dose adjustment based on glucometer and CGM glucose data trendsShare CGM data on admission and on discharge from the hospital

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Difference in mean glucose levels between subjects in intervention vs control group
Measured over From admission date to discharge date up to 8 weeks.
+1 more outcome measured

Conditions

Diabetes Mellitus

Explore related trials

Diabetes Mellitus

Where it's being run

1 sites across 1 states
Florida1

Study leadership

  • Adrian G Dumitrascu, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic

Who to contact

Adrian G Dumitrascu, MD
[email protected]
9049532000
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

What this trial measures

  • Difference in mean glucose levels between subjects in intervention vs control groupFrom admission date to discharge date up to 8 weeks.

    Difference in mean glucose levels between subjects in intervention vs control group

  • Difference in Time in Range (time spent with CGM values between 70-180 mg/dl) between subjects in intervention and control cohortsFrom admission date to discharge date up to 8 weeks.

    Difference in Time in Range (time spent with CGM values between 70-180 mg/dl) between subjects in intervention and control cohorts